Kaizen Advisory’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q3
Sell
-11,317
Closed -$1.46M 593
2018
Q2
$1.46M Buy
11,317
+8,497
+301% +$1.1M 0.74% 15
2018
Q1
$291K Buy
+2,820
New +$291K 0.29% 36